섹션 설정
RCI002
Cell Therapy for neuropathic pain
Proof of Concept
Development Objective
Prevalance & Market
RCI002
Cell Therapy for neuropathic pain
Proof of Concept
Development Objective
Prevalance & Market
Please enter 8 to 20 characters including English, numbers, and special characters.
Company Name RudaCure Co., Ltd
CEO Yong Ho Kim | CPO Seunghoon Kim
Location HQ: R302, BRC1, 9, Songdomirae-ro, Yeonsu-gu, Incheon, Republic of Korea
Seoul Office : R1001, 145, Gasan digital 1-ro, Geumcheon-gu, Seoul, Republic of Korea
US Office : 40W, 37th St. Suite 801 New York, NY 10018
Corportate registration number 548-86-00995
COPYRIGHT (C) LOGO. All Rights reserved
Company Name RudaCure Co., Ltd | CEO Yong Ho Kim | CPO Seunghoon Kim
Location
HQ&Research Institute R302, BRC1, 9, Songdomirae-ro, Yeonsu-gu, Incheon, Republic of Korea
Seoul Office R1001, 145, Gasan digital 1-ro, Geumcheon-gu, Seoul, Republic of Korea
US Office 40W, 37th St. Suite 801 New York, NY 10018
Corportate registration number 548-86-00995
COPYRIGHT (C) RUDACURE. All Rights reserved